GSK
GSK plcCompany with tickers: GSK, GLAXF
CIK
1131399
CUSIP
37733W204
Shares Outstanding
2,004,414,458
13F Activity (30d)
423 filings
408 filers
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 6-K | 2026-06-10 | — | |
| 6-K | 2026-06-09 | — | |
| 6-K | 2026-06-08 | — | |
| 6-K | 2026-06-01 | — | |
| 6-K | 2026-05-28 | — | |
| 6-K | 2026-05-27 | — | |
| 6-K | 2026-05-26 | — | |
| 6-K | 2026-05-22 | — | |
| 6-K | 2026-05-20 | — | |
| 6-K | 2026-05-19 | — | |
| 6-K | 2026-05-18 | — | |
| 6-K | 2026-05-14 | — | |
| 6-K | 2026-05-11 | — | |
| 6-K | 2026-05-06 | — | |
| 6-K | 2026-05-05 | — | |
| 6-K | 2026-05-01 | — | |
| 6-K | 2026-04-29 | — | |
| 6-K | 2026-04-28 | — | |
| 6-K | 2026-04-27 | — | |
| 6-K | 2026-04-24 | — | |
| 6-K | 2026-04-23 | — | |
| 6-K | 2026-04-22 | — | |
| 6-K | 2026-04-21 | — | |
| 6-K | 2026-04-20 | — | |
| 6-K | 2026-04-17 | — | |
| 6-K | 2026-04-16 | — | |
| 6-K | 2026-04-15 | — | |
| 6-K | 2026-04-14 | — | |
| 6-K | 2026-04-13 | — | |
| 6-K | 2026-04-10 | — | |
| 6-K | 2026-04-09 | — | |
| 6-K | 2026-04-08 | — | |
| 6-K | 2026-04-07 | — | |
| 6-K | 2026-04-02 | — | |
| 6-K | 2026-04-01 | — | |
| 6-K | 2026-03-31 | — | |
| 6-K | 2026-03-30 | — | |
| 6-K | 2026-03-27 | — | |
| 6-K | 2026-03-26 | — | |
| 6-K | 2026-03-25 | — | |
| 6-K | 2026-03-24 | — | |
| 6-K | 2026-03-23 | — | |
| 6-K | 2026-03-20 | — | |
| 6-K | 2026-03-19 | — | |
| 6-K | 2026-03-18 | — | |
| 6-K | 2026-03-17 | — | |
| 6-K | 2026-03-16 | — | |
| 6-K | 2026-03-13 | — | |
| 6-K | 2026-03-12 | — | |
| 6-K | 2026-03-11 | — |
Showing 1–50 of 834 filings